UNICA IRIS Institutional Research Information System

CRISPONI, GUIDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 159.532
NA - Nord America 9.966
AS - Asia 1.319
AF - Africa 18
OC - Oceania 14
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 2
Totale 170.862
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 156.544
US - Stati Uniti d'America 9.880
UA - Ucraina 1.120
CN - Cina 942
SE - Svezia 615
DE - Germania 457
GB - Regno Unito 281
FI - Finlandia 275
SG - Singapore 210
FR - Francia 90
CA - Canada 77
RU - Federazione Russa 42
IN - India 41
KR - Corea 36
VN - Vietnam 31
IR - Iran 28
BE - Belgio 23
AU - Australia 14
ES - Italia 14
NL - Olanda 13
CH - Svizzera 8
IE - Irlanda 8
MX - Messico 8
BR - Brasile 7
MU - Mauritius 7
CZ - Repubblica Ceca 6
RO - Romania 6
TR - Turchia 6
AT - Austria 5
PL - Polonia 5
SK - Slovacchia (Repubblica Slovacca) 5
EG - Egitto 4
JP - Giappone 4
GR - Grecia 3
SY - Repubblica araba siriana 3
BG - Bulgaria 2
DZ - Algeria 2
EU - Europa 2
ID - Indonesia 2
IQ - Iraq 2
IS - Islanda 2
MA - Marocco 2
MN - Mongolia 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
BW - Botswana 1
EC - Ecuador 1
GD - Grenada 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PK - Pakistan 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
TW - Taiwan 1
VE - Venezuela 1
Totale 170.862
Salva come PNG Salva come JPEG
Città #
Cagliari 155.831
Fairfield 1.439
Woodbridge 1.072
Houston 801
Chandler 767
Ashburn 713
Wilmington 608
Jacksonville 604
Ann Arbor 597
Seattle 551
Cambridge 508
Nyköping 439
Dearborn 295
Nanjing 194
Boardman 193
Boston 149
Helsinki 107
Beijing 100
Singapore 98
Shanghai 81
San Diego 70
Escalaplano 69
Nanchang 69
New York 68
Shenyang 56
Hebei 52
Milan 52
Redwood City 52
Guangzhou 50
Jiaxing 43
Changsha 42
Toronto 41
Tianjin 38
Verona 36
Los Angeles 35
Mountain View 34
Norwalk 33
Dong Ket 30
Orange 29
Seoul 29
Atlanta 28
Sassari 28
Jinan 26
Zhengzhou 25
Ottawa 24
Brussels 23
Ningbo 22
London 21
Hefei 18
Auburn Hills 17
Cedar Knolls 16
Pars 16
Pune 15
Bari 12
Rome 12
Washington 12
Falls Church 11
Hangzhou 11
Redmond 8
Sinalunga 8
Spin 8
Taizhou 8
Dublin 7
Fuzhou 7
Kilburn 7
Altedo 6
Borås 6
Chicago 6
Kunming 6
San Mateo 6
Bologna 5
Dallas 5
Iglesias 5
Messina 5
Padova 5
Phoenix 5
Saint Petersburg 5
Wuhan 5
Acerra 4
Bergamo 4
Chengdu 4
Florence 4
Genoa 4
Indiana 4
Islington 4
Nitra 4
Paris 4
Perugia 4
Sacramento 4
Shaoxing 4
Vancouver 4
Wuxi 4
Augusta 3
Esslingen am Neckar 3
Forest City 3
Frankfurt am Main 3
Linz 3
Miami 3
Millbury 3
Neuss 3
Totale 166.615
Salva come PNG Salva come JPEG
Nome #
Iron Chelation for Iron Overload in Thalassemia 3.955
A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity 3.464
Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one 3.372
Complex formation equilibria of Cu2 + and Zn2 + with Irbesartan and Losartan 3.284
Multiple Sclerosis and environmental factors. 3.100
para-Aminosalicylic acid in the treatment of manganese toxicity. Complexation of Mn2+ with 4-amino-2-hydroxybenzoic acid and its N-acetylated metabolite 3.068
Metal coordination and tyrosinase inhibition studies with Kojic-βAla-Kojic 2.746
Searching for new aluminium chelating agents: a family of hydroxypyrone ligands 2.569
Looking at new ligands for chelation therapy 2.237
A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe3+, Al3+, Cu2+ and Zn2+, and in vivo bioassays 2.219
A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies 2.197
The essential metals for humans: a brief overview 2.138
Do anti-diabetic drugs act as copper ligands? 2.078
Kojic acid derivatives as powerful chelators for iron(III) and aluminium(III) 2.062
Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives 2.061
A review on coordination properties of thiol-containing chelating agents towards mercury, cadmium, and lead 1.940
Toxicity of nanoparticles: etiology and mechanisms 1.939
Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators 1.933
New strong extrafunctionalizable tris(3,4-HP) and bis(3,4-HP) metal sequestering agents: synthesis, solution and in vivo metal chelation 1.901
Chelation therapy for metal intoxication. Comments from a thermodynamic view point 1.860
Equilibrium studies of new bis-hydroxypyrone derivatives with Fe3+, Al3+, Cu2+ and Zn2+ 1.840
Gold nanoparticles: A new golden Era in oncology? 1.819
Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds 1.811
Complex formation equilibria of polyamine ligands with copper(II) and zinc(II) 1.799
Kill or cure: Misuse of chelation therapy for human diseases 1.798
The meaning of aluminium exposure on human health and aluminium-related diseases 1.792
A new hydroxypyrone powerful chelator. From synthesis to AlIII, FeIII, CuII and ZnII complex formation equilibria, and structural characterization 1.778
Substituent effects on ionization constants as a predictive tool of coordinating ability 1.769
Editorial: Applications of Medicinal Bioinorganic Chemistry 1.749
Silver coordination compounds: A new horizon in medicine 1.729
Chemical features of in use and in progress chelators for iron overload 1.706
State of art in chelating agents for the clinical treatment of metal poisoning 1.701
An NMR study on the 6,6'-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with Al(III) and Zn(II) ions 1.682
Iron III and aluminium III complexes with substituted salicyl-aldehydes and salicylic acids 1.680
Alarming use of chelation therapy 1.678
Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one, with Al(III), Cu(II) and Zn(II) ions 1.666
Comparison of selectivity of a family of chelating agents for trivalent (Al3+, Fe3+) and bivalent (Cu2+, Zn2+) metal ions 1.658
Hydroxypyrones, an intriguing family of chelating agents for Fe(III) and Al(III) 1.653
Chelating agents as therapeutic compounds - Basic principles 1.600
Noble metals in medicine: Latest advances 1.596
Arsenic toxicity: Molecular targets and therapeutic agents 1.591
(5-Hydroxy-4-oxo-4H-pyran-2-yl)methyl3-({[(5-hydroxy-4-oxo-4H-pyran-2-yl)methoxy] carbonyl}amino) propanoate. Synthesis and its complex formation study 1.589
A family of hydroxypyrone ligands designed and synthesized for iron chelators 1.555
A speciation study on the perturbing effects of iron chelators on the homeostasis of essential metal ions 1.463
Uneven hepatic copper distribution in Wilson's disease 1.451
Pyridoxamine driven selective turn-off detection of picric acid using glutathione stabilized fluorescent copper nanoclusters and its applications with chemically modified cellulose strips 1.348
Uneven hepatic iron and phosphorus distribution in b-thalassemia 1.317
Three-in-one type fluorescent sensor based on a pyrene pyridoxal cascade for the selective detection of Zn(ii), hydrogen phosphate and cysteine 1.280
The Role of Magnesium in Pregnancy and in Fetal Programming of Adult Diseases 1.268
null 1.188
Chelating agents for metal intoxication 1.170
Metal ion toxicity 1.170
Insights on alpha lipoic and dihydrolipoic acids as promising scavengers of oxidative stress and possible chelators in mercury toxicology 1.127
Analytical determination of total acidity in some Sardinian wines: evaluation of the contribute of different acids 1.106
Warns against unapproved ‘chelation therapy’ 1.075
null 1.075
Iron chelating agents for iron overload diseases 1.037
Metal ions in the pathogenesis of Alzheimer’s disease: an open field 984
Substituent effect on the stability of iron(III)-salicylate complexes. Structure of trans-[Fe(H5Nsal) 2(H2O)2]Cl·2H2O 978
A new hydroxypyrone chelating agent for FeIII and AlIII: a structural and equilibrium study 973
The Potential Clinical Properties of Magnesium 957
Substituent effects on ionisation and 13C NMR properties of some monosubstituted phenols. A potentiometric, spectrophotometric and 13C NMR study 945
Sampling variability in hepatic iron concentration in beta-thalassemia 916
Kojic derivatives: a promising class of iron(III) chelators 889
Potentiometric and spectrophotometric equilibrium study on Fe(III) and new catechol-bisphosphonate conjugates 855
null 845
Enhancement of g-aminobutyric acid binding by Quazepam, a benzodiazepine derivative with preferential affinity for type I benzodiazepine receptors 842
A spectroscopic study on ionization of 2-, 3- and 4-aminopyridines 836
Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono- and di-acetyl metabolites 833
Chemometric methods applied to an ICP-AES study of chemical element distributions in autopsy livers from subjects affected by Wilson’s disease and beta-thalassemia 824
Uneven cardiac iron distribution in beta-thalassemia 807
Different approaches to the study of chelating agents for iron and aluminium overload pathologies 806
The outer/inner sphere dichotomy in the reaction of some adenine-like N-ligands with [Cu(H2EDTA)(H2O)] chelate 798
Anomalies of the oral cavity in newborns 783
Preface 776
Thermodynamic Study of Oxidovanadium(IV) with Kojic Acid Derivatives: A Multi-Technique Approach 759
Nickel binding sites in histone proteins: spectroscopic and structural characterization 739
Aluminium dependent human diseases, and chelating properties of aluminium chelators for bio-medical applications 737
A Chemometric analysis of metal ion content in Sardinian wines 721
Manganese and cobalt binding in a multi-histidinic fragment 717
The aging kidney—as influenced by heavy metal exposure and selenium supplementation 700
Complex formation equilibria of copper(II) with triethylentetramine and its human acetyl metabolites 690
null 678
null 666
Chelating Agents in Soil Remediation: A New Method for a Pragmatic Choice of the Right Chelator 661
Stress and ß-carbolines decrease the density of low affinity Gaba binding sites; an effect reversed by diazepam 656
Divalent metal-acetate complexes in concentrated aqueous solutions. An X-ray diffraction and NMR spectroscopy study 629
Calculation of spectra parameters in several spectra by contemporary decomposition in the constituent Gaussian peaks 619
Changes in the characteristics of low affinity of Gaba binding sites elicited by Ro15-1788 603
Equilibrium constants of the Fe(III)dopamine system in aqueous solution 599
null 598
Bisphosphonate chelating agents: complexation of Fe(III) and Al(III) by 1-phenyl-1-hydroxymethylene bisphosphonate and its analogues 582
Structural correlations in nickel(II)-thiodiacetato complexes: molecular and crystal structures and properties of [Ni(tda)(H2O)(3)] 575
State of art in the treatment of metal toxicity 571
null 567
SUBSTITUENT EFFECTS OF NITRO GROUP ON THE COMPLEX FORMATION EQUILIBRIA OF SALICYLIC ACID AND CATECHOL WITH Fe(III) AND Al(III) IONS 564
Substituent effect on carbon-13 chemical shifts of 3-(para substituted benzoyl)-5-amino-1,2,4-oxadiazoles 541
THIODIACETATE-COPPER(II) CHELATES WITH OR WITHOUT N-HETEROCYCLIC DONOR LIGANDS. CRYSTAL STRUCTURES OF [CU(TDA)]N, [CU(TDA)(HIM)2(H2O)] AND [CU(TDA)(5MPHEN)].2H2O 521
null 519
Adduct formation of some tris (N, N dialkyl-di thiocarbamato) Cr(III) complexes with iodine 514
Totale 137.810
Salva come PNG Salva come JPEG
Categoria #
all - tutte 217.263
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 217.263
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202030.815 0 1.217 235 670 11.651 7.623 4.046 1.037 802 802 836 1.896
2020/202149.188 1.530 1.722 2.460 11.583 9.479 6.362 4.999 3.278 1.210 2.699 2.162 1.704
2021/20228.541 1.083 959 497 772 751 678 521 326 596 687 881 790
2022/202311.356 922 1.154 1.175 826 942 1.268 548 1.937 802 571 719 492
2023/202412.856 746 532 575 997 1.394 2.210 1.777 829 517 1.068 1.120 1.091
2024/20258.667 7.253 1.414 0 0 0 0 0 0 0 0 0 0
Totale 171.275